In Law360, Health Care Attorneys Analyze Clinical Trial Law Promoting Diversity
In a Law360 article, health care partners David Peloquin and Mark Barnes and associate Carmen Lam examined the Food and Drug Omnibus Reform Act, which includes several provisions intended to promote diversity in clinical trial enrollment, encourage the growth of decentralized clinical trials and streamline clinical trials. The authors note the guidance documents required by FDORA are likely to provide helpful clarity in several key areas for clinical trial sponsors, investigators, sites and institutional review boards.